Upcoming Event: Stay tuned for further updates here!
Know More About Speclipse
Skin cancer is the easiest cancer to find, yet a confirmed diagnosis takes time, skills, and expert judgment, along with various diagnostic tests like dermoscopy and biopsy. With Spectra-Scope®, physicians can make instant, scar-free, and highly accurate diagnosis for all types of skin cancers. It is simple to use. The combination of biochemical information on skin tissue as determined through laser-induced plasma spectroscopy plus the proprietary AI-based diagnostic algorithm create an almost immediate diagnosis of unrivaled clinical accuracy in both sensitivity and specificity.
Speclipse, Inc., a medical device company founded by Stanford University graduates and a dermatologist, offers the world first cancer diagnostic solution based on Laser-Induced Plasma Spectroscopy (LIPS) and Artificial Intelligence (AI) Technology. Its core technology, Spectra-Scope®, embodies a new solution to the diagnosis of skin cancers without compromising efficacy and accuracy, therefore preventing unnecessary biopsy.
Girish S. Munavalli, MD, MHS, FACMS
Dermatology, Laser & Vein Specialists of the Carolinas
Charlotte, North Carolina, USA
“... Spectrascope is a painless, rapid, and reliable method for diagnosis of suspicious lesions at the point of care ... Spectra-Scope can pinpoint the probability of a malignant vs. benign lesion within minutes, sparing the patient the pain of a biopsy ...”
Dr Samuel Seit, MBBS(UNSW), Dip Pr Derm Distinction (Cardiff), Dip Laser Surg(ACCS), FRACGP, FCPCA, FASLMS
The Skin Cancer & Cosmetic Clinic
Neutral bay, New South Wales, Australia
"... Spectra-scope gives a very quick idea whether decision is to biopsy a lesion, or even to go cut it off ..."
Boncheol Leo Goo, MD
Board-certified Dermatologist / Mohs micrographic surgeon
Naeum Skin Clinic
"... Although skin biopsy is the gold standard, still it is an invasive procedure and when the patients repeatedly need regular follow-up tests, they can be huge burden.... Spectra-scope is so impressive not only for the caregivers, but also to the patients by it’s a painless, rapid, and reliable method for the diagnosis of suspicious lesions, in a real-time manner ..."